Trials / Completed
CompletedNCT01372280
Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition
Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Dr. Reddy's Laboratories, Ltd. and Janssen Pharmaceutical Products, l.P. (Reminyl®)4 mg Galantamine HBr Tablets in Healthy Adult Male Volunteers Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 28 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Galantamine Hydrobromide Tablets, Bioequivalence study of Dr. Reddy's under Fasting condition.
Detailed description
Comparative, Randomized, Single-Dose. 2-way Crossover Bioavailability Study of Dr.Reddy's laboratories, ltd. and Janssen Pharmaceutical Products. L.P. (Reminyte®)4 mg Galantamine HBr Tablets In Healthy Adult Male Volunteers under fasting Conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Reminyl | Galantamine Hydrobromide Tablets 4 mg |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2004-10-01
- Completion
- 2004-11-01
- First posted
- 2011-06-13
- Last updated
- 2011-06-30
Source: ClinicalTrials.gov record NCT01372280. Inclusion in this directory is not an endorsement.